NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 23 04:00PM ET
0.3200
Dollar change
-0.0100
Percentage change
-3.03
%
Index- P/E- EPS (ttm)-47.81 Insider Own5.46% Shs Outstand0.53M Perf Week-37.13%
Market Cap0.16M Forward P/E- EPS next Y-1.29 Insider Trans0.00% Shs Float0.50M Perf Month-92.64%
Enterprise Value-0.95M PEG- EPS next Q-2.57 Inst Own77.83% Short Float12.41% Perf Quarter-95.04%
Income-13.06M P/S0.38 EPS this Y92.20% Inst Trans0.79% Short Ratio0.01 Perf Half Y-95.46%
Sales0.43M P/B0.10 EPS next Y74.56% ROA-282.74% Short Interest0.06M Perf YTD-96.82%
Book/sh3.13 P/C0.15 EPS next 5Y- ROE-800.00% 52W High24.00 -98.67% Perf Year-97.86%
Cash/sh2.15 P/FCF- EPS past 3/5Y77.27% 63.29% ROIC-1020.63% 52W Low0.30 5.12% Perf 3Y-99.97%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-0.13% -19.05% Gross Margin-39.40% Volatility14.43% 28.33% Perf 5Y-100.00%
Dividend TTM- EV/Sales-2.20 EPS Y/Y TTM59.34% Oper. Margin-3331.34% ATR (14)0.41 Perf 10Y-100.00%
Dividend Ex-Date- Quick Ratio1.13 Sales Y/Y TTM-35.03% Profit Margin-3010.14% RSI (14)21.51 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.69 EPS Q/Q83.50% SMA20-82.88% Beta1.15 Target Price60.00
Payout- Debt/Eq0.00 Sales Q/Q-63.70% SMA50-90.43% Rel Volume0.93 Prev Close0.33
Employees21 LT Debt/Eq0.00 EarningsMay 08 SMA200-95.66% Avg Volume5.62M Price0.32
IPOJun 27, 2014 Option/ShortNo / Yes EPS/Sales Surpr.11.26% -51.00% Trades Volume5,244,523 Change-3.03%
Date Action Analyst Rating Change Price Target Change
Mar-24-21Initiated Noble Capital Markets Outperform $20
Jun-16-25 07:00AM
Jun-12-25 07:00AM
Jun-11-25 07:00AM
Jun-04-25 09:12PM
07:00AM
07:00AM Loading…
May-20-25 07:00AM
May-12-25 07:00AM
Apr-30-25 09:00AM
Mar-13-25 07:00AM
Mar-11-25 07:00AM
Jan-22-25 07:00AM
Jan-21-25 08:00PM
07:00AM
Dec-23-24 07:00AM
Nov-18-24 08:01AM
08:00AM Loading…
08:00AM
Oct-18-24 08:00AM
Oct-14-24 05:00PM
Sep-30-24 08:00AM
Aug-16-24 05:00PM
Aug-12-24 04:05PM
Aug-06-24 04:36PM
Jun-28-24 06:00AM
Jun-17-24 07:00AM
Jun-06-24 07:38AM
07:00AM
May-31-24 12:30PM
May-29-24 09:00AM
May-23-24 09:00AM
May-20-24 09:00AM
08:53PM Loading…
May-13-24 08:53PM
04:05PM
May-10-24 09:00AM
May-08-24 07:31AM
May-07-24 07:39AM
May-06-24 10:15PM
09:00AM
May-03-24 08:12AM
07:31AM
Apr-24-24 09:05AM
Apr-03-24 07:05AM
Apr-01-24 12:18PM
Mar-28-24 04:05PM
Mar-15-24 07:05AM
Mar-12-24 08:59AM
Mar-07-24 07:00AM
Mar-04-24 07:00AM
Feb-06-24 07:00AM
Feb-05-24 07:05AM
Jan-11-24 07:00AM
Dec-07-23 09:55AM
Nov-30-23 07:47AM
Nov-13-23 11:07AM
Nov-09-23 04:05PM
Nov-06-23 07:05AM
Nov-02-23 05:05PM
Oct-20-23 02:34PM
Oct-12-23 07:05AM
Oct-02-23 07:05AM
Sep-28-23 07:00AM
Sep-21-23 07:05AM
Sep-20-23 07:05AM
Sep-13-23 07:05AM
Sep-06-23 09:55AM
Sep-05-23 07:00AM
Aug-16-23 09:00AM
Aug-13-23 08:13AM
Aug-11-23 07:33AM
Aug-10-23 06:15PM
04:05PM
Aug-07-23 07:05AM
Aug-02-23 04:05PM
Jul-27-23 07:05AM
Jun-20-23 07:05AM
Jun-14-23 04:05PM
May-25-23 07:05AM
May-24-23 07:05AM
May-19-23 05:00PM
May-16-23 12:14PM
May-12-23 06:31AM
May-11-23 04:05PM
May-04-23 04:05PM
Apr-17-23 07:05AM
Apr-16-23 06:30AM
Mar-24-23 12:29PM
Mar-23-23 05:00PM
Mar-22-23 07:05AM
Mar-10-23 06:22AM
Mar-09-23 04:05PM
07:05AM
Mar-06-23 07:30AM
Mar-02-23 04:05PM
Feb-15-23 07:05AM
Jan-23-23 07:05AM
Jan-19-23 09:00AM
Jan-10-23 07:05AM
Jan-05-23 07:41AM
Jan-03-23 07:05AM
Dec-30-22 04:05PM
Nov-17-22 12:00PM
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.